NROM Noble Romans (NROM) Insider Trading, Ownership & Congress Trades
Restaurants & Leisure · Retail-eating places · CIK 0000709005
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about NROM
Insiders, 180 days
-$3.8K net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$3.5K
1 notice
Noble Romans insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, NOBLE ROMANS INC insiders sold a net $3.8K of stock across 57 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 1.7% of the 320,000 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Coape-Arnold Douglas Harold sold about $3.8K of NROM on Aug 27, 2026, the largest insider sale at the company since 2024.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 9, 2021.
- The trade is 600.0% of the 10,000 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Herbst Marcel sold about $20.4K of NROM on Nov 24, 2024, the largest insider sale at the company since 2021.Context
- 36 earlier Form 4 trades (code P or S) here by this insider (36 sales), the last on Feb 1, 2022.
- The trade is 0.9% of the 2,178,465 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Stiller Robert P sold about $6.8K of NROM on Feb 2, 2022.Context
- 35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Jan 31, 2022.
- The trade is 0.9% of the 2,198,452 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Stiller Robert P sold about $6.5K of NROM on Feb 1, 2022.Context
- 34 earlier Form 4 trades (code P or S) here by this insider (34 sales), the last on Jan 28, 2022.
- The trade is 0.6% of the 2,217,163 shares held after it.
- No other insider sold within 30 days.
Insider activity: Insider Stiller Robert P sold about $4.8K of NROM on Jan 31, 2022.57 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$3.8K over 180 days
-$3.8K over 90 days
more than 75% of Restaurants & Leisure
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+7.4% year over year
more than 58% of Restaurants & Leisure
Margin
7.2% net margin
more than 72% of Restaurants & Leisure
Buybacks
no share repurchases reported
Short interest
<0.1% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 90% of Restaurants & Leisure
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch NROM
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+233.3%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns NROM: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in NROM
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
NROM planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Coape-Arnold Douglas Harold
Filed 2026-09-01
$3.5K
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.8K sold by insiders over 180 days, $3.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
NROM financials
Revenue growth
+7.4%
XBRL, annual
Net margin
7.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$16.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NROM
| FY Dec 2025 | $16.5M |
| FY Dec 2024 | $15.1M |
| FY Dec 2023 | $14.4M |
| FY Dec 2022 | $14.5M |
| FY Dec 2021 | n/a |
| Jun 2026 | $4.1M |
| Mar 2026 | $3.9M |
| Dec 2025 | $4.5M |
| Sep 2025 | $4.1M |
| Jun 2025 | $4.1M |
| Mar 2025 | $3.8M |
| Dec 2024 | $3.7M |
| Sep 2024 | $3.9M |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | -0.0% |
| FY Dec 2023 | +10.2% |
| FY Dec 2022 | -9.1% |
| FY Dec 2021 | n/a |
| Jun 2026 | +4.6% |
| Mar 2026 | +6.0% |
| Dec 2025 | +0.7% |
| Sep 2025 | +15.4% |
| Jun 2025 | +7.0% |
| Mar 2025 | +3.5% |
| Dec 2024 | -4.5% |
| Sep 2024 | +5.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM NROM
| FY Dec 2025 | $1.1M |
| FY Dec 2024 | $725.3K |
| FY Dec 2023 | $1.6M |
| FY Dec 2022 | -$478.0K |
| FY Dec 2021 | $69.2K |
| Jun 2026 | $771.4K |
| Mar 2026 | $280.7K |
| Dec 2025 | $299.5K |
| Sep 2025 | $267.4K |
| Jun 2025 | $429.3K |
| Mar 2025 | $104.4K |
| Dec 2024 | $296.2K |
| Sep 2024 | $408 |
At each fiscal year end
Single quarter
Debt to equity
0.92x
long-term debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity NROM
| FY Dec 2025 | 1.02x |
| FY Dec 2024 | 1.98x |
| FY Dec 2023 | 2.36x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.92x |
| Mar 2026 | 0.99x |
| Dec 2025 | 1.02x |
| Sep 2025 | 1.29x |
| Jun 2025 | 1.71x |
| Mar 2025 | 1.93x |
| Dec 2024 | 1.98x |
| Sep 2024 | 2.18x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.50x
TTM operating cash flow over long-term debt only, 2025-12-31 (6 months older than the period end)
Cash flow to debt NROM
| FY Dec 2025 | 0.35x |
| FY Dec 2024 | 0.19x |
| FY Dec 2023 | 0.30x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.50x |
| Mar 2026 | 0.41x |
| Dec 2025 | 0.35x |
| Sep 2025 | 0.28x |
| Jun 2025 | 0.21x |
| Mar 2025 | 0.09x |
| Dec 2024 | 0.19x |
| Sep 2024 | 0.19x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | -0.1% |
| FY Dec 2023 | +100.7% |
| FY Dec 2022 | -72.9% |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | +30.9% |
| Jun 2025 | +18.7% |
| Mar 2025 | +9.8% |
| Dec 2024 | -0.1% |
| Sep 2024 | +12.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | -0.0% |
| FY Dec 2023 | +7.9% |
| FY Dec 2022 | -7.0% |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | +5.4% |
| Jun 2025 | +2.6% |
| Mar 2025 | +1.2% |
| Dec 2024 | -0.0% |
| Sep 2024 | +1.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +59.3% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | +28.5% |
| Jun 2025 | +29.1% |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | +10.4% |
| FY Dec 2023 | +23.2% |
| FY Dec 2022 | +2.6% |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | +28.6% |
| Jun 2025 | +17.5% |
| Mar 2025 | +14.7% |
| Dec 2024 | +10.4% |
| Sep 2024 | +17.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.00x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing NROM
| FY Dec 2025 | 7.00x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 4.71x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 14.00x |
| Jun 2026 | 12.80x |
| Mar 2026 | 7.00x |
| Dec 2025 | 7.00x |
| Sep 2025 | 4.50x |
| Jun 2025 | 10.50x |
| Mar 2025 | 32.00x |
| Dec 2024 | n/a |
| Sep 2024 | 16.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$16.6M
market value at close 2026-10-27 on 2026-08-03 shares, plus long-term debt only, 2025-12-31 (6 months older than the period end), minus cash 2024-09-30
Enterprise value NROM
| FY Dec 2025 | $10.7M |
| FY Dec 2024 | $11.6M |
| FY Dec 2023 | $11.6M |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | $17.2M |
| Mar 2026 | $10.7M |
| Dec 2025 | $10.7M |
| Sep 2025 | $7.8M |
| Jun 2025 | $8.5M |
| Mar 2025 | $10.9M |
| Dec 2024 | $11.6M |
| Sep 2024 | $11.7M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield NROM
| FY Dec 2025 | +14.2% |
| FY Dec 2024 | +9.3% |
| FY Dec 2023 | +21.2% |
| FY Dec 2022 | -8.0% |
| FY Dec 2021 | +0.7% |
| Jun 2026 | +11.4% |
| Mar 2026 | +16.4% |
| Dec 2025 | +14.2% |
| Sep 2025 | +27.4% |
| Jun 2025 | +17.8% |
| Mar 2025 | +4.0% |
| Dec 2024 | +9.3% |
| Sep 2024 | +13.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.08x
P/E over trailing EPS growth of 150%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing NROM
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.09x |
| Mar 2026 | 0.02x |
| Dec 2025 | n/a |
| Sep 2025 | 0.05x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $16.5M | $15.1M | $14.4M | $14.5M |
| Operating income | $2.4M | $1.5M | $3.4M | $427.7K |
| Net income | $1.2M | -$3.2K | $1.5M | -$1.3M |
| EPS (diluted) | 0.04 | 0.00 | 0.07 | -0.06 |
| Operating cash flow | $1.2M | $813.6K | $1.6M | $29.6K |
| Cash | n/a | n/a | $872.3K | $785.5K |
| Long-term debt | $3.5M | $4.4M | $5.2M | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
NROM Stock Sonar score 4/7 axes
Find similar shapesCompareNROM ranks highest on risk and compliance (67th percentile) and financial health (63rd), and lowest on insider conviction (38th), among Restaurants & Leisure peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NROM filings, in plain words
Are Noble Romans insiders buying or selling NROM?
In the 180 days to 2026-10-28, Noble Romans insiders were net sellers, a net $3.8K across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of NROM?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $3.5K of stock; the latest, by Coape-Arnold Douglas Harold, was filed 2026-09-01.
Read the full summary
In the 180 days to 2026-10-28, Noble Romans insiders were net sellers of NROM, a net $3.8K across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $3.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
